dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Martínez Gómez, Xavier |
dc.contributor.author | Curran Fàbregas, Adria |
dc.contributor.author | Alemany Vilches, Laia |
dc.contributor.author | Rodrigo Pendás, Jose Angel |
dc.contributor.author | Borruel Sainz, Natalia |
dc.contributor.author | Díaz de Heredia Rubio, Maria Cristina |
dc.contributor.author | Moraga Llop, Fernando |
dc.contributor.author | Campins Martí, Magda |
dc.date.accessioned | 2019-03-28T11:23:03Z |
dc.date.available | 2019-03-28T11:23:03Z |
dc.date.issued | 2019-02-14 |
dc.identifier.citation | Martínez-Gómez X, Curran A, Campins M, Alemany L, Rodrigo-Pendás JÁ, Borruel N, et al. Multidisciplinary, evidence-based consensus guidelines for human papillomavirus (HPV) vaccination in high-risk populations, Spain, 2016. Euro Surveill. 2019;24(7):1700857. |
dc.identifier.issn | 1560-7917 |
dc.identifier.uri | https://hdl.handle.net/11351/3882 |
dc.description | High-risk populations; Human papillomavirus infection; Vaccines |
dc.description.abstract | INTRODUCTION:
Although human papillomavirus (HPV) routine vaccination programmes have been implemented around the world and recommendations have been expanded to include other high-risk individuals, current recommendations often differ between countries in Europe, as well as worldwide.
AIM:
To find and summarise the best available evidence of HPV vaccination in high-risk patients aiding clinicians and public health workers in the day-to-day vaccine decisions relating to HPV in Spain.
METHODS:
We conducted a systematic review of the immunogenicity, safety and efficacy/effectiveness of HPV vaccination in high-risk populations between January 2006 and June 2016. HPV vaccination recommendations were established with levels of evidence according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system.
RESULTS:
A strong recommendation about HPV vaccination was made in the following groups: HIV infected patients aged 9-26 years; men who have sex with men aged 9-26 years; women with precancerous cervical lesions; patients with congenital bone marrow failure syndrome; women who have received a solid organ transplant or hematopoietic stem cell transplantation aged 9-26 years; and patients diagnosed with recurrent respiratory papillomatosis.
CONCLUSIONS:
Data concerning non-routine HPV vaccination in populations with a high risk of HPV infection and associated lesions were scarce. We have developed a document to evaluate and establish evidence-based guidelines on HPV vaccination in high-risk populations in Spain, based on best available scientific evidence. |
dc.language.iso | eng |
dc.publisher | European Centre for Disease Prevention and Control |
dc.relation.ispartofseries | Eurosurveillance;24(7) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Papil·lomavirus - Vacunació - Espanya |
dc.subject.mesh | Papillomavirus Infections |
dc.subject.mesh | Papillomavirus Vaccines |
dc.subject.mesh | Spain |
dc.subject.mesh | /epidemiology |
dc.title | Multidisciplinary, evidence-based consensus guidelines for human papillomavirus (HPV) vaccination in high-risk populations, Spain, 2016 |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.2807/1560-7917.ES.2019.24.7.1700857 |
dc.subject.decs | infecciones por Papillomavirus |
dc.subject.decs | vacunas para papilomavirus |
dc.subject.decs | España |
dc.subject.decs | /epidemiología |
dc.relation.publishversion | https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2019.24.7.1700857 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Martínez-Gómez X] Servei de Medicina Preventiva i Epidemiologia, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Curran A] Servei de Malalties Infeccioses, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Campins M] Servei de Medicina Preventiva i Epidemiologia, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Alemany L] Programa de Recerca en Epidemiologia del Càncer, Institut Català d'Oncologia - IDIBELL CIBER Epidemiología y Salud Pública, Barcelona, Spain. [Rodrigo-Pendás JÁ] Servei de Medicina Preventiva i Epidemiologia, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Borruel N] Unitat d'Atenció Crohn-Colitis, Servei d'Aparell Digestiu, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Díaz-de-Heredia C] Servei d'Oncologia i Hematologia Pediàtrica, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Moraga-Llop FA] Asociación Española de Vacunología, Barcelona, Spain. |
dc.identifier.pmid | 30782268 |
dc.identifier.wos | WOS:000458642200002 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |